Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank17
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-8.69M
↓ 57% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-5.54M
Historical baseline
PeriodValueYoY Change
2025$-8.69M-369.8%
2024$-1.85M+73.7%
2023$-7.02M+48.3%
2022$-13.59M-85.6%
2021$-7.32M-2438.0%
2020$-288392.00-586.5%
2019$-42009.00-